MetaADEDB 2.0 @ LMMD
4-Aminopyridine
(NUKYPUAOHBNCPY-UHFFFAOYSA-N)
Structure
SMILES
Nc1ccncc1
Type(s)
Approved
ATC code(s)
N07XX07
Molecular Formula:
C5H6N2
Molecular Weight:
94.115
Log P:
1.2450
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
1
TPSA:
38.91
CAS Number(s):
504-24-5; 29212-32-6
Synonym(s)
1.
4-Aminopyridine
2.
4-Aminopyridine Sustained Release
3.
Dalfampridine
4.
Fampridine-SR
5.
Pymadine
6.
VMI-103
7.
4 Aminopyridine
8.
4 Aminopyridine Sustained Release
9.
Fampridine SR
10.
Sustained Release, 4-Aminopyridine
11.
VMI 103
12.
VMI103
External Link(s)
MeSHD015761
PubChem Compound1727
BindingDB10458
ChEBI34385
CHEMBLCHEMBL284348
DrugBankDB06637
DrugCentral4163
IUPHAR/BPS Guide to PHARMACOLOGY2416
KEGGcpd:C13728
dr:D04127
Therapeutic Target DatabaseD08YIN
ZINC599985
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 3290
Canada Vigilance: 165
Canada Vigilance
US FAERS
2Therapy cessationFAERS: 1637US FAERS
3Urinary tract infectionFAERS: 1159
Canada Vigilance: 26
Canada Vigilance
US FAERS
4DizzinessFAERS: 1114
Canada Vigilance: 21
Canada Vigilance
US FAERS
5FatigueFAERS: 791
Canada Vigilance: 22
Canada Vigilance
US FAERS
6HeadacheFAERS: 748
Canada Vigilance: 10
Canada Vigilance
US FAERS
7Activities of daily living impairedFAERS: 733US FAERS
8Drug dose omissionFAERS: 678US FAERS
9Multiple sclerosis relapseFAERS: 677
Canada Vigilance: 21
Canada Vigilance
US FAERS
10Inappropriate schedule of drug administrationFAERS: 650US FAERS
11AstheniaFAERS: 611
Canada Vigilance: 18
Canada Vigilance
US FAERS
12MalaiseFAERS: 563
Canada Vigilance: 8
Canada Vigilance
US FAERS
13Impaired work abilityFAERS: 555US FAERS
14NauseaFAERS: 540
Canada Vigilance: 14
Canada Vigilance
US FAERS
15Memory impairmentFAERS: 496
Canada Vigilance: 2
Canada Vigilance
US FAERS
16Multiple SclerosisFAERS: 470
Canada Vigilance: 14
19915712CTD
Canada Vigilance
US FAERS
17Back PainFAERS: 459
Canada Vigilance: 5
Canada Vigilance
US FAERS
18PainFAERS: 395
Canada Vigilance: 10
Canada Vigilance
US FAERS
19Therapeutic response unexpectedFAERS: 375
Canada Vigilance: 2
Canada Vigilance
US FAERS
20ConstipationFAERS: 339
Canada Vigilance: 6
Canada Vigilance
US FAERS
21Feeling abnormalFAERS: 315
Canada Vigilance: 4
Canada Vigilance
US FAERS
22AbasiaFAERS: 305US FAERS
23TremorFAERS: 267
Canada Vigilance: 9
24378259CTD
Canada Vigilance
US FAERS
24Adverse eventFAERS: 257
Canada Vigilance: 1
Canada Vigilance
US FAERS
25Extra dose administeredFAERS: 252US FAERS
26NasopharyngitisFAERS: 181
Canada Vigilance: 4
Canada Vigilance
US FAERS
27PruritusFAERS: 180US FAERS
28Abdominal discomfortFAERS: 178
Canada Vigilance: 1
Canada Vigilance
US FAERS
29Walking aid userFAERS: 175US FAERS
30AnxietyFAERS: 172
Canada Vigilance: 3
Canada Vigilance
US FAERS
31VomitingFAERS: 172
Canada Vigilance: 7
Canada Vigilance
US FAERS
32FlushingFAERS: 154US FAERS
33Musculoskeletal stiffnessFAERS: 151
Canada Vigilance: 7
Canada Vigilance
US FAERS
34Product dose omissionFAERS: 147
Canada Vigilance: 12
Canada Vigilance
US FAERS
35Incorrect dose administeredFAERS: 136US FAERS
36PneumoniaFAERS: 134
Canada Vigilance: 17
Canada Vigilance
US FAERS
37ArthralgiaFAERS: 130
Canada Vigilance: 9
Canada Vigilance
US FAERS
38Burning sensationFAERS: 129
Canada Vigilance: 1
Canada Vigilance
US FAERS
39Gait inabilityFAERS: 129
Canada Vigilance: 12
Canada Vigilance
US FAERS
40InfluenzaFAERS: 123
Canada Vigilance: 4
Canada Vigilance
US FAERS
41Wheelchair userFAERS: 116US FAERS
42DysgraphiaFAERS: 114US FAERS
43Loss of personal independence in daily activitiesFAERS: 114US FAERS
44AlopeciaFAERS: 112US FAERS
45Peripheral swellingFAERS: 112
Canada Vigilance: 5
Canada Vigilance
US FAERS
46CystitisFAERS: 107
Canada Vigilance: 6
Canada Vigilance
US FAERS
47Inappropriate schedule of product administrationFAERS: 105
Canada Vigilance: 1
Canada Vigilance
US FAERS
48Limb discomfortFAERS: 100
Canada Vigilance: 4
Canada Vigilance
US FAERS
49HypersensitivityFAERS: 96
Canada Vigilance: 3
Canada Vigilance
US FAERS
50Muscle SpasticityFAERS: 90
Canada Vigilance: 3
Canada Vigilance
US FAERS
51InfectionFAERS: 88
Canada Vigilance: 3
Canada Vigilance
US FAERS
52Visual ImpairmentFAERS: 88
Canada Vigilance: 2
Canada Vigilance
US FAERS
53SomnolenceFAERS: 83
Canada Vigilance: 1
Canada Vigilance
US FAERS
54Weight decreasedFAERS: 78
Canada Vigilance: 2
Canada Vigilance
US FAERS
55Oropharyngeal painFAERS: 77
Canada Vigilance: 1
Canada Vigilance
US FAERS
56HypokinesiaFAERS: 76US FAERS
57Drug ineffective for unapproved indicationFAERS: 75US FAERS
58AmnesiaFAERS: 74
Canada Vigilance: 1
Canada Vigilance
US FAERS
59DyspepsiaFAERS: 73
Canada Vigilance: 3
Canada Vigilance
US FAERS
60DysuriaFAERS: 73
Canada Vigilance: 3
Canada Vigilance
US FAERS
61VertigoFAERS: 72
Canada Vigilance: 2
Canada Vigilance
US FAERS
62Cerebrovascular accidentFAERS: 71
Canada Vigilance: 4
Canada Vigilance
US FAERS
63StressFAERS: 70
Canada Vigilance: 5
Canada Vigilance
US FAERS
64Central nervous system lesionFAERS: 69US FAERS
65NephrolithiasisFAERS: 69
Canada Vigilance: 2
Canada Vigilance
US FAERS
66SepsisFAERS: 67
Canada Vigilance: 2
Canada Vigilance
US FAERS
67White blood cell count decreasedFAERS: 66
Canada Vigilance: 1
Canada Vigilance
US FAERS
68General physical health deteriorationFAERS: 65
Canada Vigilance: 2
Canada Vigilance
US FAERS
69MyalgiaFAERS: 65
Canada Vigilance: 3
Canada Vigilance
US FAERS
70Escherichia urinary tract infectionFAERS: 64US FAERS
71UrticariaFAERS: 64
Canada Vigilance: 1
Canada Vigilance
US FAERS
72Depressed moodFAERS: 63
Canada Vigilance: 2
Canada Vigilance
US FAERS
73PalpitationsFAERS: 61
Canada Vigilance: 3
Canada Vigilance
US FAERS
74Myocardial InfarctionFAERS: 60
Canada Vigilance: 4
Canada Vigilance
US FAERS
75Product use in unapproved indicationFAERS: 60US FAERS
76Ankle FractureFAERS: 59
Canada Vigilance: 7
Canada Vigilance
US FAERS
77Contraindicated product administeredFAERS: 58US FAERS
78DehydrationFAERS: 57
Canada Vigilance: 3
Canada Vigilance
US FAERS
79No adverse eventFAERS: 57US FAERS
80Urinary IncontinenceFAERS: 55
Canada Vigilance: 2
Canada Vigilance
US FAERS
81ChillsFAERS: 51
Canada Vigilance: 4
Canada Vigilance
US FAERS
82Disease ProgressionFAERS: 51US FAERS
83Medication ErrorFAERS: 50US FAERS
84Temperature intoleranceFAERS: 50
Canada Vigilance: 3
Canada Vigilance
US FAERS
85BedriddenFAERS: 46US FAERS
86Feeling jitteryFAERS: 46US FAERS
87Muscle tightnessFAERS: 46
Canada Vigilance: 1
Canada Vigilance
US FAERS
88BronchitisFAERS: 45
Canada Vigilance: 1
Canada Vigilance
US FAERS
89Drug effect incompleteFAERS: 45US FAERS
90Joint swellingFAERS: 45US FAERS
91SinusitisFAERS: 45US FAERS
92Trigeminal NeuralgiaFAERS: 45
Canada Vigilance: 2
Canada Vigilance
US FAERS
93CellulitisFAERS: 44
Canada Vigilance: 5
Canada Vigilance
US FAERS
94Chest PainFAERS: 44
Canada Vigilance: 1
Canada Vigilance
US FAERS
95SyncopeFAERS: 42US FAERS
96Abdominal PainFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
97ArthropathyFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
98Therapeutic product ineffective for unapproved indicationFAERS: 41US FAERS
99ErythemaFAERS: 40
Canada Vigilance: 1
Canada Vigilance
US FAERS
100IncontinenceFAERS: 40US FAERS
101AphasiaFAERS: 39
Canada Vigilance: 3
Canada Vigilance
US FAERS
102DiplopiaFAERS: 39US FAERS
103HemiparesisFAERS: 39
Canada Vigilance: 1
Canada Vigilance
US FAERS
104NervousnessFAERS: 39
Canada Vigilance: 1
Canada Vigilance
US FAERS
105Culture urine positiveFAERS: 38US FAERS
106Mental impairmentFAERS: 38US FAERS
107NeuralgiaFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
108B-lymphocyte count decreasedFAERS: 37US FAERS
109DisorientationFAERS: 36US FAERS
110DysarthriaFAERS: 35
Canada Vigilance: 2
Canada Vigilance
US FAERS
111Lymphocyte count decreasedFAERS: 35US FAERS
112Throat irritationFAERS: 35US FAERS
113ChromaturiaFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
114EpilepsyFAERS: 347705426
8667248
CTD
US FAERS
115Urinary RetentionFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
116AgitationFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
117Limb injuryFAERS: 33
Canada Vigilance: 2
Canada Vigilance
US FAERS
118Neck PainFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
119PregnancyFAERS: 31US FAERS
120Urine leukocyte esterase positiveFAERS: 31US FAERS
121DisabilityFAERS: 30US FAERS
122Joint injuryFAERS: 30
Canada Vigilance: 2
Canada Vigilance
US FAERS
123ArthritisFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
124Blood urine presentFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
125Emotional distressFAERS: 29US FAERS
126LethargyFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
127Blood creatinine increasedFAERS: 28US FAERS
128Initial insomniaFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
129LacerationFAERS: 28US FAERS
130Living in residential institutionFAERS: 28US FAERS
131DiscomfortFAERS: 27
Canada Vigilance: 4
Canada Vigilance
US FAERS
132DysphoniaFAERS: 27US FAERS
133Feeling ColdFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
134Pulmonary EmbolismFAERS: 27
Canada Vigilance: 2
Canada Vigilance
US FAERS
135HypersomniaFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
136TinnitusFAERS: 26
Canada Vigilance: 3
Canada Vigilance
US FAERS
137Musculoskeletal PainFAERS: 25US FAERS
138AtaxiaFAERS: 24
Canada Vigilance: 1
24378259CTD
Canada Vigilance
US FAERS
139Chest discomfortFAERS: 24US FAERS
140DementiaFAERS: 24US FAERS
141Restless Legs SyndromeFAERS: 24US FAERS
142ThrombosisFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
143Cardiac ArrestFAERS: 23US FAERS
144HypotensionFAERS: 23
Canada Vigilance: 1
9249246CTD
Canada Vigilance
US FAERS
145Product substitution issueFAERS: 23US FAERS
146Middle insomniaFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
147SwellingFAERS: 22US FAERS
148CataractFAERS: 21US FAERS
149CryingFAERS: 21US FAERS
150Dry skinFAERS: 21US FAERS
151Alanine Aminotransferase IncreasedFAERS: 20US FAERS
152Back disorderFAERS: 20US FAERS
153General symptomFAERS: 20
Canada Vigilance: 2
Canada Vigilance
US FAERS
154Optic NeuritisFAERS: 20
Canada Vigilance: 2
Canada Vigilance
US FAERS
155AngerFAERS: 19US FAERS
156Blood potassium decreasedFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
157Accidental overdoseFAERS: 18US FAERS
158Carpal Tunnel SyndromeFAERS: 18US FAERS
159Eye painFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
160JC virus test positiveFAERS: 18US FAERS
161Blood glucose increasedFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
162ColitisFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
163FlatulenceFAERS: 17US FAERS
164Impaired driving abilityFAERS: 17US FAERS
165InflammationFAERS: 17US FAERS
166Poor quality sleepFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
167CholelithiasisFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
168Clostridium difficile infectionFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
169EpistaxisFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
170Progressive multiple sclerosisFAERS: 16US FAERS
171Rash erythematousFAERS: 16US FAERS
172RestlessnessFAERS: 16US FAERS
173Spinal column stenosisFAERS: 16US FAERS
174Wrong technique in product usage processFAERS: 16US FAERS
175Deep Vein ThrombosisFAERS: 15US FAERS
176Diabetes MellitusFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
177DysgeusiaFAERS: 15US FAERS
178Intestinal ObstructionFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
179Joint stiffnessFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
180Mental status changesFAERS: 15US FAERS
181Mood swingsFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
182OsteoporosisFAERS: 15US FAERS
183Therapy non-responderFAERS: 15
Canada Vigilance: 54
Canada Vigilance
US FAERS
184Aspartate Aminotransferase IncreasedFAERS: 14US FAERS
185Atrial FibrillationFAERS: 14US FAERS
186GlaucomaFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
187ImmobileFAERS: 14US FAERS
188LaryngitisFAERS: 14US FAERS
189OverdoseFAERS: 14US FAERS
190PancreatitisFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
191Protein urine presentFAERS: 14US FAERS
192Bacterial test positiveFAERS: 13US FAERS
193BlindnessFAERS: 13US FAERS
194Blood immunoglobulin M decreasedFAERS: 13US FAERS
195Facial PainFAERS: 13US FAERS
196Frustration tolerance decreasedFAERS: 13US FAERS
197GoutFAERS: 13US FAERS
198Productive CoughFAERS: 13US FAERS
199SluggishnessFAERS: 13US FAERS
200Urine ketone body presentFAERS: 13US FAERS
201Arthropod biteFAERS: 12US FAERS
202Blood alkaline phosphatase increasedFAERS: 12US FAERS
203ChokingFAERS: 12US FAERS
204Escherichia test positiveFAERS: 12US FAERS
205Full blood count abnormalFAERS: 12US FAERS
206MonoplegiaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
207Night sweatsFAERS: 12US FAERS
208Ocular icterusFAERS: 12US FAERS
209Skin UlcerFAERS: 12US FAERS
210Unevaluable eventFAERS: 12US FAERS
211AcneFAERS: 11US FAERS
212Blood urea increasedFAERS: 11US FAERS
213CD4 Lymphocytes DecreasedFAERS: 11US FAERS
214ClumsinessFAERS: 11US FAERS
215Cold sweatFAERS: 11US FAERS
216Contraindicated drug administeredFAERS: 11US FAERS
217DiplegiaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
218EructationFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
219Injection site bruisingFAERS: 11US FAERS
220Injection site painFAERS: 11US FAERS
221Lip swellingFAERS: 11US FAERS
222Nasal discomfortFAERS: 11US FAERS
223PneumothoraxFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
224PresyncopeFAERS: 11US FAERS
225SciaticaFAERS: 11US FAERS
226Skin irritationFAERS: 11US FAERS
227Stem cell transplantFAERS: 11US FAERS
228T-lymphocyte count increasedFAERS: 11US FAERS
229TachycardiaFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
230Blood cholesterol increasedFAERS: 10US FAERS
231Cerebral disorderFAERS: 10US FAERS
232Injection Site ReactionFAERS: 10US FAERS
233Insurance issueFAERS: 10US FAERS
234Lymphocyte percentage decreasedFAERS: 10US FAERS
235MenopauseFAERS: 10US FAERS
236Muscle FatigueFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
237Rehabilitation therapyFAERS: 10US FAERS
238Renal painFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
239Respiratory FailureFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
240Respiratory arrestFAERS: 10US FAERS
241Rotator cuff syndromeFAERS: 10US FAERS
242Vitamin D DeficiencyFAERS: 10US FAERS
243Wrong technique in drug usage processFAERS: 10US FAERS
244AtelectasisFAERS: 9US FAERS
245B-lymphocyte count abnormalFAERS: 9US FAERS
246Basal cell carcinomaFAERS: 9US FAERS
247Blood iron decreasedFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
248Blood sodium decreasedFAERS: 9US FAERS
249Blood thyroid stimulating hormone decreasedFAERS: 9US FAERS
250Bone painFAERS: 9US FAERS
251Creatinine renal clearance decreasedFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
252Emotional disorderFAERS: 9US FAERS
253Gastric ulcerFAERS: 9US FAERS
254Injection site erythemaFAERS: 9US FAERS
255Injection site pruritusFAERS: 9US FAERS
256Ligament ruptureFAERS: 9US FAERS
257Medication residue presentFAERS: 9US FAERS
258Muscle strainFAERS: 9US FAERS
259OsteomyelitisFAERS: 9US FAERS
260Pancreatic carcinomaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
261Product use issueFAERS: 9US FAERS
262Spinal column injuryFAERS: 9US FAERS
263Urinary tract infection enterococcalFAERS: 9US FAERS
264AbscessFAERS: 8US FAERS
265Acute kidney injuryFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
266Blood count abnormalFAERS: 8US FAERS
267CD4 lymphocytes increasedFAERS: 8US FAERS
268Expired product administeredFAERS: 8US FAERS
269FormicationFAERS: 8US FAERS
270FractureFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
271Head discomfortFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
272HemiplegiaFAERS: 8US FAERS
273Low density lipoprotein increasedFAERS: 8US FAERS
274Muscle RigidityFAERS: 8US FAERS
275Musculoskeletal chest painFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
276Nerve injuryFAERS: 8US FAERS
277Neutrophil count decreasedFAERS: 8US FAERS
278NocturiaFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
279Post procedural complicationFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
280Pulmonary congestionFAERS: 8US FAERS
281Quality of life decreasedFAERS: 8US FAERS
282Renal massFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
283Septic ShockFAERS: 8US FAERS
284Status EpilepticusFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
285Unresponsive to stimuliFAERS: 8US FAERS
286White blood cell count abnormalFAERS: 8US FAERS
287nervous system disorderFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
288skin abrasionFAERS: 8US FAERS
289AsthmaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
290Blood immunoglobulin G decreasedFAERS: 7US FAERS
291CD8 lymphocytes decreasedFAERS: 7US FAERS
292Catheter placementFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
293DiverticulitisFAERS: 7US FAERS
294Drug administration errorFAERS: 7US FAERS
295Drug effect variableFAERS: 7US FAERS
296Drug withdrawal syndromeFAERS: 7US FAERS
297Erectile dysfunctionFAERS: 7US FAERS
298Intervertebral Disc DegenerationFAERS: 7US FAERS
299Limb operationFAERS: 7US FAERS
300PharyngitisFAERS: 7US FAERS
301PsoriasisFAERS: 7US FAERS
302Rheumatoid ArthritisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
303Seizure like phenomenaFAERS: 7US FAERS
304Skin lesionFAERS: 7US FAERS
305Tooth InfectionFAERS: 7US FAERS
306Tooth LossFAERS: 7US FAERS
307Urge IncontinenceFAERS: 7US FAERS
308Urinary hesitationFAERS: 7US FAERS
309Vulvovaginal pruritusFAERS: 7US FAERS
310Bladder painFAERS: 6US FAERS
311Blood albumin decreasedFAERS: 6US FAERS
312Blood triglycerides increasedFAERS: 6US FAERS
313DeafnessFAERS: 6US FAERS
314DeliriumFAERS: 6US FAERS
315Facial NeuralgiaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
316Facial paralysisFAERS: 6US FAERS
317Flank PainFAERS: 6US FAERS
318Focal dyscognitive seizuresFAERS: 6US FAERS
319Food PoisoningFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
320HypothyroidismFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
321Impaired self-careFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
322LymphopeniaFAERS: 6US FAERS
323Monocyte count increasedFAERS: 6US FAERS
324NystagmusFAERS: 6US FAERS
325Personality ChangeFAERS: 6US FAERS
326PhotophobiaFAERS: 6US FAERS
327Prescribed overdoseFAERS: 6US FAERS
328RetchingFAERS: 6US FAERS
329TensionFAERS: 6US FAERS
330Terminal stateFAERS: 6US FAERS
331Therapeutic response changedFAERS: 6US FAERS
332Urinary tract infection pseudomonalFAERS: 6US FAERS
333Vitreous floatersFAERS: 6US FAERS
334Accidental exposure to product by childFAERS: 5US FAERS
335AgeusiaFAERS: 5US FAERS
336Angina PectorisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
337AphoniaFAERS: 5US FAERS
338Bipolar DisorderFAERS: 5US FAERS
339BlepharospasmFAERS: 5US FAERS
340Blood chloride decreasedFAERS: 5US FAERS
341Blood creatinine abnormalFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
342Blood potassium abnormalFAERS: 5US FAERS
343Blood potassium increasedFAERS: 5US FAERS
344Blood thyroid stimulating hormone increasedFAERS: 5US FAERS
345BradyphreniaFAERS: 5US FAERS
346BursitisFAERS: 5US FAERS
347Completed SuicideFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
348ConjunctivitisFAERS: 5US FAERS
349CystFAERS: 5US FAERS
350Dental cariesFAERS: 5US FAERS
351Diet refusalFAERS: 5US FAERS
352Drug effect delayedFAERS: 5US FAERS
353Drug prescribing errorFAERS: 5US FAERS
354DystoniaFAERS: 5US FAERS
355Economic problemFAERS: 5US FAERS
356EczemaFAERS: 5US FAERS
357Excessive cerumen productionFAERS: 5US FAERS
358Fear of fallingFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
359FibromyalgiaFAERS: 5US FAERS
360Gastrointestinal PainFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
361General physical condition abnormalFAERS: 5US FAERS
362Hospice CareFAERS: 5US FAERS
363HyperventilationFAERS: 5US FAERS
364Injection site massFAERS: 5US FAERS
365Intentional product use issueFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
366Klebsiella test positiveFAERS: 5US FAERS
367Lactose IntoleranceFAERS: 5US FAERS
368Lower respiratory tract infectionFAERS: 5US FAERS
369LymphadenopathyFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
370Lymphocyte count abnormalFAERS: 5US FAERS
371Product physical issueFAERS: 5US FAERS
372Pulmonary arterial hypertensionFAERS: 5US FAERS
373Retinal DetachmentFAERS: 5US FAERS
374Sinus headacheFAERS: 5US FAERS
375Slow speechFAERS: 5US FAERS
376Spinal fusion surgeryFAERS: 5US FAERS
377Subcutaneous EmphysemaFAERS: 5US FAERS
378ThrombocytopeniaFAERS: 5US FAERS
379Tongue discomfortFAERS: 5US FAERS
380Tooth ExtractionFAERS: 5US FAERS
381Vitamin B12 abnormalFAERS: 5US FAERS
382Walking distance test abnormalFAERS: 5
Canada Vigilance: 4
Canada Vigilance
US FAERS
383Wound infection staphylococcalFAERS: 5US FAERS
384Actinic keratosisFAERS: 4US FAERS
385AkinesiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
386AnhedoniaFAERS: 4US FAERS
387Animal biteFAERS: 4US FAERS
388ApathyFAERS: 4US FAERS
389AsthenopiaFAERS: 4US FAERS
390Bacterial sepsisFAERS: 4US FAERS
391Bladder dysfunctionFAERS: 4US FAERS
392Blood creatinine decreasedFAERS: 4US FAERS
393Blood glucose abnormalFAERS: 4US FAERS
394Blood glucose decreasedFAERS: 4US FAERS
395Blood magnesium decreasedFAERS: 4US FAERS
396Bowel movement irregularityFAERS: 4US FAERS
397Cardiac FlutterFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
398Citrobacter infectionFAERS: 4US FAERS
399Compression fractureFAERS: 4US FAERS
400Contraindicated drug prescribedFAERS: 4US FAERS
401DemyelinationFAERS: 4US FAERS
402Device related infectionFAERS: 4US FAERS
403Drug DependenceFAERS: 4US FAERS
404DysphemiaFAERS: 4US FAERS
405Enterococcus test positiveFAERS: 4US FAERS
406Gastric BypassFAERS: 4US FAERS
407GastritisFAERS: 4US FAERS
408GastroenteritisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
409Gastrointestinal motility disorderFAERS: 4US FAERS
410Grip strength decreasedFAERS: 4US FAERS
411Guillain-Barre SyndromeFAERS: 4US FAERS
412HerniaFAERS: 4US FAERS
413Hip surgeryFAERS: 4US FAERS
414Hypertensive crisisFAERS: 4US FAERS
415Inability to afford medicationFAERS: 4US FAERS
416IncoherentFAERS: 4US FAERS
417JC polyomavirus test positiveFAERS: 4US FAERS
418Joint InstabilityFAERS: 4US FAERS
419Lyme DiseaseFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
420Lymphocyte count increasedFAERS: 4US FAERS
421MastectomyFAERS: 4US FAERS
422MenorrhagiaFAERS: 4US FAERS
423MetamorphopsiaFAERS: 4US FAERS
424Oral painFAERS: 4US FAERS
425ParanoiaFAERS: 4US FAERS
426ParaparesisFAERS: 4US FAERS
427PolyuriaFAERS: 4US FAERS
428Prescribed underdoseFAERS: 4
Canada Vigilance: 5
Canada Vigilance
US FAERS
429Product quality issueFAERS: 4US FAERS
430Pseudomonas test positiveFAERS: 4US FAERS
431Pulmonary thrombosisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
432RegurgitationFAERS: 4US FAERS
433Sexual DysfunctionFAERS: 4US FAERS
434Skin PapillomaFAERS: 4US FAERS
435Skin lacerationFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
436SneezingFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
437StomatitisFAERS: 4US FAERS
438Suicide attemptFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
439Therapy changeFAERS: 4US FAERS
440ThrombophlebitisFAERS: 4US FAERS
441Uhthoff's phenomenonFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
442UlcerFAERS: 4US FAERS
443Viral upper respiratory tract infectionFAERS: 4US FAERS
444treatment failureFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
445Acute respiratory failureFAERS: 3US FAERS
446Alcohol poisoningFAERS: 3US FAERS
447Amyotrophic Lateral SclerosisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
448AppendicitisFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
449Autonomic nervous system imbalanceFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
450B-lymphocyte count increasedFAERS: 3US FAERS
451Bipolar I disorderFAERS: 3US FAERS
452Bladder spasmFAERS: 3US FAERS
453Blood 25-hydroxycholecalciferol decreasedFAERS: 3US FAERS
454Blood blisterFAERS: 3US FAERS
455Blood chloride increasedFAERS: 3US FAERS
456Blood cholesterol abnormalFAERS: 3US FAERS
457Blood cholesterolFAERS: 3US FAERS
458Blood creatine phosphokinase increasedFAERS: 3US FAERS
459Blood parathyroid hormone increasedFAERS: 3US FAERS
460Blood testosterone decreasedFAERS: 3US FAERS
461Blood thyroid stimulating hormone abnormalFAERS: 3US FAERS
462BruxismFAERS: 3US FAERS
463Burn infectionFAERS: 3US FAERS
464CD8 lymphocytes increasedFAERS: 3US FAERS
465CandiduriaFAERS: 3US FAERS
466Cataract operationFAERS: 3US FAERS
467Cerebellar AtaxiaFAERS: 3US FAERS
468Cerebral atrophyFAERS: 3US FAERS
469Cholecystitis infectiveFAERS: 3US FAERS
470CholecystitisFAERS: 3US FAERS
471Depressed Level of ConsciousnessFAERS: 3US FAERS
472Diabetic KetoacidosisFAERS: 3US FAERS
473DissociationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
474Drug delivery device implantationFAERS: 3US FAERS
475Escherichia infectionFAERS: 3US FAERS
476Escherichia sepsisFAERS: 3US FAERS
477ExcoriationFAERS: 3US FAERS
478Failure to ThriveFAERS: 3US FAERS
479Feeling of body temperature changeFAERS: 3US FAERS
480Fibrin D dimer increasedFAERS: 3US FAERS
481Gamma-Glutamyltransferase IncreasedFAERS: 3US FAERS
482Gastrointestinal infectionFAERS: 3US FAERS
483Genital rashFAERS: 3US FAERS
484Grief reactionFAERS: 3US FAERS
485Hand-eye coordination impairedFAERS: 3US FAERS
486Head titubationFAERS: 3US FAERS
487Heat illnessFAERS: 3US FAERS
488HypophagiaFAERS: 3US FAERS
489HysterectomyFAERS: 3US FAERS
490Incorrect drug dosage form administeredFAERS: 3US FAERS
491Increased upper airway secretionFAERS: 3US FAERS
492Intentional product misuseFAERS: 3
Canada Vigilance: 6
Canada Vigilance
US FAERS
493Joint Range of Motion DecreasedFAERS: 3US FAERS
494Labile blood pressureFAERS: 3US FAERS
495Laboratory test interferenceFAERS: 3US FAERS
496LazinessFAERS: 3US FAERS
497Lymphocyte percentage abnormalFAERS: 3US FAERS
498LymphomaFAERS: 3US FAERS
499Maternal exposure during pregnancyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
500Mouth swellingFAERS: 3US FAERS
501Musculoskeletal discomfortFAERS: 3US FAERS
502Myasthenia GravisFAERS: 3US FAERS
503NeutropeniaFAERS: 3US FAERS
504Noninfective encephalitisFAERS: 3US FAERS
505Nonspecific reactionFAERS: 3US FAERS
506OnychomycosisFAERS: 3US FAERS
507Orthosis userFAERS: 3US FAERS
508OsteopeniaFAERS: 3US FAERS
509PCO2 decreasedFAERS: 3US FAERS
510Pelvic PainFAERS: 3US FAERS
511PeriarthritisFAERS: 3US FAERS
512Periorbital contusionFAERS: 3US FAERS
513PiloerectionFAERS: 3US FAERS
514Procedural complicationFAERS: 3US FAERS
515ProteinuriaFAERS: 3US FAERS
516Proteus test positiveFAERS: 3US FAERS
517PyelonephritisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
518RhinalgiaFAERS: 3US FAERS
519ShockFAERS: 3US FAERS
520Simple Partial SeizuresFAERS: 3US FAERS
521Skin reactionFAERS: 3US FAERS
522StaringFAERS: 3US FAERS
523Streptococcus test positiveFAERS: 3US FAERS
524Subcutaneous AbscessFAERS: 3US FAERS
525Supraventricular tachycardiaFAERS: 3US FAERS
526Systemic Inflammatory Response SyndromeFAERS: 3US FAERS
527Tongue bitingFAERS: 3US FAERS
528TonsillitisFAERS: 3US FAERS
529ToothacheFAERS: 3US FAERS
530Vaginal DischargeFAERS: 3US FAERS
531Vulvovaginal mycotic infectionFAERS: 3US FAERS
532Wound InfectionFAERS: 3US FAERS
533colonoscopyFAERS: 3US FAERS
534furuncleFAERS: 3US FAERS
535Abdominal AbscessFAERS: 2US FAERS
536Accidental exposure to productFAERS: 2US FAERS
537Acute sinusitisFAERS: 2US FAERS
538AdenocarcinomaFAERS: 2US FAERS
539Alanine aminotransferase abnormalFAERS: 2US FAERS
540Anaphylactic shockFAERS: 2US FAERS
541AneurysmFAERS: 2US FAERS
542AngioedemaFAERS: 2US FAERS
543Anion gap abnormalFAERS: 2US FAERS
544Antibody test abnormalFAERS: 2US FAERS
545ArteriosclerosisFAERS: 2US FAERS
546AsphyxiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
547Atrioventricular BlockFAERS: 2US FAERS
548Atypical pneumoniaFAERS: 2US FAERS
549AuraFAERS: 2US FAERS
550Automatic bladderFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
551Bacterial VaginosisFAERS: 2US FAERS
552BacteriuriaFAERS: 2US FAERS
553Band sensationFAERS: 2US FAERS
554Base excess decreasedFAERS: 2US FAERS
555Base excess increasedFAERS: 2US FAERS
556Bladder discomfortFAERS: 2US FAERS
557Blood calcium abnormalFAERS: 2US FAERS
558Blood immunoglobulin A decreasedFAERS: 2US FAERS
559Blood immunoglobulin M abnormalFAERS: 2US FAERS
560Blood lactate dehydrogenase increasedFAERS: 2US FAERS
561Blood pH normalFAERS: 2US FAERS
562Blood pressure fluctuationFAERS: 2US FAERS
563Blood urea abnormalFAERS: 2US FAERS
564Bone contusionFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
565BradycardiaFAERS: 2US FAERS
566BradykinesiaFAERS: 2US FAERS
567Breast CystFAERS: 2US FAERS
568Breast tendernessFAERS: 2US FAERS
569Bunion operationFAERS: 2US FAERS
570Burning feet syndromeFAERS: 2US FAERS
571CD4 lymphocyte percentage decreasedFAERS: 2US FAERS
572CD4 lymphocytes abnormalFAERS: 2US FAERS
573CD4/CD8 ratio decreasedFAERS: 2US FAERS
574Cartilage atrophyFAERS: 2US FAERS
575Cerebral ThrombosisFAERS: 2US FAERS
576Cervical dysplasiaFAERS: 2US FAERS
577ChemotherapyFAERS: 2US FAERS
578ClonusFAERS: 2US FAERS
579Clostridial sepsisFAERS: 2US FAERS
580Clostridium difficile colitisFAERS: 2US FAERS
581Contraindicated product prescribedFAERS: 2US FAERS
582Coronary Artery DiseaseFAERS: 2US FAERS
583Creatinine urine decreasedFAERS: 2US FAERS
584Crystal urine presentFAERS: 2US FAERS
585Death of relativeFAERS: 2US FAERS
586Decreased immune responsivenessFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
587Depression suicidalFAERS: 2US FAERS
588Diabetes mellitus inadequate controlFAERS: 2US FAERS
589Diabetic ulcerFAERS: 2US FAERS
590Disease complicationFAERS: 2US FAERS
591Disease recurrenceFAERS: 2US FAERS
592Drug administered to patient of inappropriate ageFAERS: 2US FAERS
593Drug dispensing errorFAERS: 2US FAERS
594Drug screen positiveFAERS: 2US FAERS
595DyschromatopsiaFAERS: 2US FAERS
596Electroconvulsive TherapyFAERS: 2US FAERS
597Electrolyte imbalanceFAERS: 2US FAERS
598Endodontic procedureFAERS: 2US FAERS
599Enterococcal sepsisFAERS: 2US FAERS
600Euphoric moodFAERS: 2US FAERS
601Expanded disability status scale score increasedFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
602Expired drug administeredFAERS: 2US FAERS
603Eye irritationFAERS: 2US FAERS
604FolliculitisFAERS: 2US FAERS
605Food AllergyFAERS: 2US FAERS
606Foreign body in respiratory tractFAERS: 2US FAERS
607Gastroenteritis norovirusFAERS: 2US FAERS
608Gastrointestinal carcinomaFAERS: 2US FAERS
609Gastrointestinal stoma complicationFAERS: 2US FAERS
610GingivitisFAERS: 2US FAERS
611Gluten sensitivityFAERS: 2US FAERS
612Hepatic cancer metastaticFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
613Human papilloma virus test positiveFAERS: 2US FAERS
614HungerFAERS: 2US FAERS
615HydronephrosisFAERS: 2US FAERS
616HyperacusisFAERS: 2US FAERS
617HyperkeratosisFAERS: 2US FAERS
618Hypertensive heart diseaseFAERS: 2US FAERS
619Immune thrombocytopenic purpuraFAERS: 2US FAERS
620Impaired gastric emptyingFAERS: 2US FAERS
621Impaired quality of lifeFAERS: 2US FAERS
622Incorrect drug administration durationFAERS: 2US FAERS
623Incorrect product storageFAERS: 2US FAERS
624Injection site indentationFAERS: 2US FAERS
625Injection site irritationFAERS: 2US FAERS
626Intentional dose omissionFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
627Interventional procedureFAERS: 2US FAERS
628Intervertebral disc disorderFAERS: 2US FAERS
629Intestinal PerforationFAERS: 2US FAERS
630Intracranial AneurysmFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
631Intrathecal pump insertionFAERS: 2US FAERS
632LabyrinthitisFAERS: 2US FAERS
633Large intestine perforationFAERS: 2US FAERS
634LeukopeniaFAERS: 2US FAERS
635Light chain analysis increasedFAERS: 2US FAERS
636Lipase increasedFAERS: 2US FAERS
637Low density lipoprotein abnormalFAERS: 2US FAERS
638Lymphocyte percentage increasedFAERS: 2US FAERS
639MalabsorptionFAERS: 2US FAERS
640Marburg's variant multiple sclerosisFAERS: 2US FAERS
641Maternal exposure before pregnancyFAERS: 2US FAERS
642Medical device complicationFAERS: 2US FAERS
643MeningitisFAERS: 2US FAERS
644Meniscus injuryFAERS: 2US FAERS
645Metastatic NeoplasmFAERS: 2US FAERS
646MetrorrhagiaFAERS: 2US FAERS
647Monocyte percentage increasedFAERS: 2US FAERS
648Multiple allergiesFAERS: 2US FAERS
649Multiple drug therapyFAERS: 2US FAERS
650NephrectomyFAERS: 2US FAERS
651Nerve Root CompressionFAERS: 2US FAERS
652Neuromyelitis OpticaFAERS: 2US FAERS
653Neutrophil count abnormalFAERS: 2US FAERS
654Neutrophil percentage increasedFAERS: 2US FAERS
655Occult blood positiveFAERS: 2US FAERS
656OnychoclasisFAERS: 2US FAERS
657OphthalmoplegiaFAERS: 2US FAERS
658PO2 decreasedFAERS: 2US FAERS
659Pain of skinFAERS: 2US FAERS
660Panic DisorderFAERS: 2US FAERS
661Paranasal sinus discomfortFAERS: 2US FAERS
662Pelvic Inflammatory DiseaseFAERS: 2US FAERS
663PhlebitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
664Phobia of drivingFAERS: 2US FAERS
665Platelet count abnormalFAERS: 2US FAERS
666PolyneuropathyFAERS: 2US FAERS
667Poor peripheral circulationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
668Post-Traumatic Stress DisorderFAERS: 2US FAERS
669Precancerous cells presentFAERS: 2US FAERS
670Product availability issueFAERS: 2US FAERS
671Product prescribing issueFAERS: 2US FAERS
672Product use complaintFAERS: 2US FAERS
673Protein total decreasedFAERS: 2US FAERS
674Psychiatric symptomFAERS: 2US FAERS
675Pulmonary FibrosisFAERS: 2US FAERS
676PyodermaFAERS: 2US FAERS
677PyuriaFAERS: 2US FAERS
678Respiratory distressFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
679Rocky Mountain Spotted FeverFAERS: 2US FAERS
680RosaceaFAERS: 2US FAERS
681Salt cravingFAERS: 2US FAERS
682SarcoidosisFAERS: 2US FAERS
683ScabFAERS: 2US FAERS
684Secretion dischargeFAERS: 2US FAERS
685Sensitivity to weather changeFAERS: 2US FAERS
686Sinus TachycardiaFAERS: 2US FAERS
687Specific gravity urine abnormalFAERS: 2US FAERS
688SplenomegalyFAERS: 2US FAERS
689SpondylitisFAERS: 2US FAERS
690Squamous cell carcinoma of skinFAERS: 2US FAERS
691Staphylococcus test positiveFAERS: 2US FAERS
692Streptococcal urinary tract infectionFAERS: 2US FAERS
693Sudden deathFAERS: 2US FAERS
694Surgical failureFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
695Synovial CystFAERS: 2US FAERS
696T-lymphocyte count abnormalFAERS: 2US FAERS
697Temperature regulation disorderFAERS: 2US FAERS
698Tension HeadacheFAERS: 2US FAERS
699Therapeutic procedureFAERS: 2US FAERS
700Therapeutic product effect decreasedFAERS: 2
Canada Vigilance: 20
Canada Vigilance
US FAERS
701Thermal burnFAERS: 2US FAERS
702ThyroidectomyFAERS: 2US FAERS
703Time perception alteredFAERS: 2US FAERS
704Toxicity to various agentsFAERS: 2US FAERS
705TransplantFAERS: 2US FAERS
706TrismusFAERS: 2US FAERS
707Troponin increasedFAERS: 2US FAERS
708TuberculosisFAERS: 2US FAERS
709Unwanted pregnancyFAERS: 2US FAERS
710Upper motor neurone lesionFAERS: 2US FAERS
711Upper respiratory tract inflammationFAERS: 2US FAERS
712Urethritis noninfectiveFAERS: 2US FAERS
713Urinary sediment presentFAERS: 2US FAERS
714Urinary tract infection fungalFAERS: 2US FAERS
715Urinary tract infection staphylococcalFAERS: 2US FAERS
716Urine albumin/creatinine ratio increasedFAERS: 2US FAERS
717Urine cannabinoids increasedFAERS: 2US FAERS
718Uterine CancerFAERS: 2US FAERS
719Uterine PolypFAERS: 2US FAERS
720Vibratory sense increasedFAERS: 2US FAERS
721Vitamin B6 increasedFAERS: 2US FAERS
722Vitamin D abnormalFAERS: 2US FAERS
723Vulvovaginal discomfortFAERS: 2US FAERS
724intensive careFAERS: 2US FAERS
725jaundiceFAERS: 2US FAERS
726prostatitisFAERS: 2US FAERS
727Abdominal adhesionsFAERS: 1US FAERS
728Abdominal massFAERS: 1US FAERS
729Abdominal rigidityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
730Abnormal sleep-related eventFAERS: 1US FAERS
731Aborted pregnancyFAERS: 1US FAERS
732AcidosisFAERS: 1US FAERS
733Acquired Immunodeficiency SyndromeFAERS: 1US FAERS
734Acute HIV infectionFAERS: 1US FAERS
735Acute myocardial infarctionFAERS: 1US FAERS
736Adjustment disorder with depressed moodFAERS: 1US FAERS
737AgraphiaFAERS: 1US FAERS
738Alcohol interactionFAERS: 1US FAERS
739Alcohol withdrawal syndromeFAERS: 1US FAERS
740Allergic respiratory symptomFAERS: 1US FAERS
741Allergic sinusitisFAERS: 1US FAERS
742Allergy to vaccineFAERS: 1US FAERS
743AllodyniaFAERS: 1US FAERS
744Alpha 2 globulin abnormalFAERS: 1US FAERS
745Alpha 2 globulin increasedFAERS: 1US FAERS
746Altered state of consciousnessFAERS: 1US FAERS
747Altered visual depth perceptionFAERS: 1US FAERS
748Amphetamines positiveFAERS: 1US FAERS
749Angular cheilitisFAERS: 1US FAERS
750Animal scratchFAERS: 1US FAERS
751Anion GapFAERS: 1US FAERS
752AnosmiaFAERS: 1US FAERS
753Anti-interferon antibody positiveFAERS: 1US FAERS
754Antibiotic therapyFAERS: 1US FAERS
755Anticoagulant therapyFAERS: 1US FAERS
756AnuriaFAERS: 1US FAERS
757AphagiaFAERS: 1US FAERS
758Aphthous StomatitisFAERS: 1US FAERS
759Apparent deathFAERS: 1US FAERS
760Apparent life threatening eventFAERS: 1US FAERS
761Arthropod stingFAERS: 1US FAERS
762Aspartate aminotransferase decreasedFAERS: 1US FAERS
763Asthma-Chronic Obstructive Pulmonary Disease Overlap SyndromeFAERS: 1US FAERS
764Autoimmune hepatitisFAERS: 1US FAERS
765AversionFAERS: 1US FAERS
766B-lymphocyte abnormalitiesFAERS: 1US FAERS
767Bacterial testFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
768Basophil percentage increasedFAERS: 1US FAERS
769Benign Prostatic HyperplasiaFAERS: 1US FAERS
770Biliary ColicFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
771Bilirubin conjugated abnormalFAERS: 1US FAERS
772Bilirubin conjugated increasedFAERS: 1US FAERS
773Biopsy colon abnormalFAERS: 1US FAERS
774BlepharitisFAERS: 1US FAERS
775Blood 1,25-dihydroxycholecalciferol decreasedFAERS: 1US FAERS
776Blood Corticotrophin DecreasedFAERS: 1US FAERS
777Blood bilirubin abnormalFAERS: 1US FAERS
778Blood bilirubin unconjugated increasedFAERS: 1US FAERS
779Blood creatine increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
780Blood electrolytes decreasedFAERS: 1US FAERS
781Blood immunoglobulin A abnormalFAERS: 1US FAERS
782Blood immunoglobulin G increasedFAERS: 1US FAERS
783Blood immunoglobulin M increasedFAERS: 1US FAERS
784Blood ketone body increasedFAERS: 1US FAERS
785Blood phosphorus decreasedFAERS: 1US FAERS
786Blood pressure inadequately controlledFAERS: 1US FAERS
787Blood sodium increasedFAERS: 1US FAERS
788Blood thyroid stimulating hormoneFAERS: 1US FAERS
789Blood urea nitrogen/creatinine ratio increasedFAERS: 1US FAERS
790Bowen's DiseaseFAERS: 1US FAERS
791Brain HypoxiaFAERS: 1US FAERS
792Brain natriuretic peptide increasedFAERS: 1US FAERS
793Brain stem syndromeFAERS: 1US FAERS
794Breast cancer recurrentFAERS: 1US FAERS
795BronchiectasisFAERS: 1US FAERS
796CD30 expressionFAERS: 1US FAERS
797CD8 lymphocyte percentage increasedFAERS: 1US FAERS
798CD8 lymphocytes abnormalFAERS: 1US FAERS
799CalcinosisFAERS: 1US FAERS
800Carbon dioxide decreasedFAERS: 1US FAERS
801Carcinoembryonic antigen increasedFAERS: 1US FAERS
802Cardiac infectionFAERS: 1US FAERS
803Cardiac monitoringFAERS: 1US FAERS
804Cardiac valve ruptureFAERS: 1US FAERS
805CardiomegalyFAERS: 1US FAERS
806Carotid Artery ThrombosisFAERS: 1US FAERS
807Carotid EndarterectomyFAERS: 1US FAERS
808Carotid artery occlusionFAERS: 1US FAERS
809Carotid artery perforationFAERS: 1US FAERS
810Central Nervous System InfectionFAERS: 1US FAERS
811Cerebral InfarctionFAERS: 1US FAERS
812Cervix carcinoma stage IVFAERS: 1US FAERS
813CholangitisFAERS: 1US FAERS
814CholelithotomyFAERS: 1US FAERS
815CholestasisFAERS: 1US FAERS
816Chronic respiratory failureFAERS: 1US FAERS
817ClaustrophobiaFAERS: 1US FAERS
818Clostridium test positiveFAERS: 1US FAERS
819Coating in mouthFAERS: 1US FAERS
820CoccidioidomycosisFAERS: 1US FAERS
821ColectomyFAERS: 1US FAERS
822Colon adenomaFAERS: 1US FAERS
823Complication associated with deviceFAERS: 1US FAERS
824Concomitant disease progressionFAERS: 1US FAERS
825Congenital neuropathyFAERS: 1US FAERS
826Corrosive gastritisFAERS: 1US FAERS
827Critical IllnessFAERS: 1US FAERS
828Culture positiveFAERS: 1US FAERS
829Cystic FibrosisFAERS: 1US FAERS
830Cystitis escherichiaFAERS: 1US FAERS
831Cytomegalovirus hepatitisFAERS: 1US FAERS
832Deafness PermanentFAERS: 1US FAERS
833Death of petFAERS: 1US FAERS
834Delayed sleep phaseFAERS: 1US FAERS
835Delusional disorder, unspecified typeFAERS: 1US FAERS
836Dental Restoration FailureFAERS: 1US FAERS
837Device difficult to useFAERS: 1US FAERS
838Device dislocationFAERS: 1US FAERS
839Device occlusionFAERS: 1US FAERS
840Diabetic NephropathyFAERS: 1US FAERS
841Diastolic hypertensionFAERS: 1US FAERS
842Diffuse Large B-Cell LymphomaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
843Drug abuseFAERS: 1US FAERS
844Drug level below therapeuticFAERS: 1US FAERS
845Drug specific antibody presentFAERS: 1US FAERS
846Drug withdrawal convulsionsFAERS: 1US FAERS
847DyscalculiaFAERS: 1US FAERS
848DysenteryFAERS: 1US FAERS
849DyslexiaFAERS: 1US FAERS
850Ear congestionFAERS: 1US FAERS
851Ear discomfortFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
852Eating disorder symptomFAERS: 1US FAERS
853Ectopic PregnancyFAERS: 1US FAERS
854Electrocardiogram ST segment abnormalFAERS: 1US FAERS
855Electrocardiogram abnormalFAERS: 1US FAERS
856Electroencephalogram abnormalFAERS: 1US FAERS
857EmbolismFAERS: 1US FAERS
858Emotional povertyFAERS: 1US FAERS
859Enamel anomalyFAERS: 1US FAERS
860EndocarditisFAERS: 1US FAERS
861EndometriosisFAERS: 1US FAERS
862Enteral NutritionFAERS: 1US FAERS
863Enterobacter test positiveFAERS: 1US FAERS
864Eosinophil percentage increasedFAERS: 1US FAERS
865ErysipelasFAERS: 1US FAERS
866ErythromelalgiaFAERS: 1US FAERS
867Essential HypertensionFAERS: 1US FAERS
868Evans syndromeFAERS: 1US FAERS
869Exposure to toxic agentFAERS: 1US FAERS
870Eye complication associated with deviceFAERS: 1US FAERS
871Eyeglasses therapyFAERS: 1US FAERS
872Eyelid irritationFAERS: 1US FAERS
873Factor V Leiden mutationFAERS: 1US FAERS
874Failure to anastomoseFAERS: 1US FAERS
875Febrile infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
876Feeding tube complicationFAERS: 1US FAERS
877Feeding tube userFAERS: 1US FAERS
878Fluid imbalanceFAERS: 1US FAERS
879Foaming at mouthFAERS: 1US FAERS
880ForaminotomyFAERS: 1US FAERS
881Foreign body aspirationFAERS: 1US FAERS
882Foreign body sensation in eyesFAERS: 1US FAERS
883Freezing phenomenonFAERS: 1US FAERS
884FrustrationFAERS: 1US FAERS
885Gait deviationFAERS: 1US FAERS
886GangreneFAERS: 1US FAERS
887GastrectomyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
888Gastric infectionFAERS: 1US FAERS
889Gastrointestinal inflammationFAERS: 1US FAERS
890Gastrointestinal perforationFAERS: 1US FAERS
891Gastrointestinal sounds abnormalFAERS: 1US FAERS
892Gastrointestinal tract adenomaFAERS: 1US FAERS
893Gastrointestinal viral infectionFAERS: 1US FAERS
894GastrostomyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
895Genital infectionFAERS: 1US FAERS
896Gingival discomfortFAERS: 1US FAERS
897Glioblastoma MultiformeFAERS: 1US FAERS
898GlioblastomaFAERS: 1US FAERS
899Granulocytes abnormalFAERS: 1US FAERS
900GranulomaFAERS: 1US FAERS
901Hand repair operationFAERS: 1US FAERS
902Heart valve stenosisFAERS: 1US FAERS
903Heat ExhaustionFAERS: 1US FAERS
904Heat StrokeFAERS: 1US FAERS
905HepatitisFAERS: 1US FAERS
906HepatomegalyFAERS: 1US FAERS
907HepatotoxicityFAERS: 1US FAERS
908Herpes zoster infection neurologicalFAERS: 1US FAERS
909HordeolumFAERS: 1US FAERS
910Human papilloma virus test negativeFAERS: 1US FAERS
911HyperchlorhydriaFAERS: 1US FAERS
912HypergeusiaFAERS: 1US FAERS
913HyperthyroidismFAERS: 1US FAERS
914Hyporesponsive to stimuliFAERS: 1US FAERS
915HypospadiasFAERS: 1US FAERS
916HypoxiaFAERS: 1US FAERS
917IleusFAERS: 1US FAERS
918Illness anxiety disorderFAERS: 1US FAERS
919ImmunosuppressionFAERS: 1US FAERS
920Impaired reasoningFAERS: 1US FAERS
921Incision site infectionFAERS: 1US FAERS
922Increased tendency to bruiseFAERS: 1US FAERS
923IndurationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
924InfarctionFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
925Injection site atrophyFAERS: 1US FAERS
926Injection site infectionFAERS: 1US FAERS
927Injection site urticariaFAERS: 1US FAERS
928Injection site vesiclesFAERS: 1US FAERS
929Intention tremorFAERS: 1US FAERS
930Intervertebral disc compressionFAERS: 1US FAERS
931Intracranial massFAERS: 1US FAERS
932Intrauterine infectionFAERS: 1US FAERS
933Invasive Lobular Breast CarcinomaFAERS: 1US FAERS
934Irritable Bowel SyndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
935JC virus infectionFAERS: 1US FAERS
936JC virus testFAERS: 1US FAERS
937Joint laxityFAERS: 1US FAERS
938Lactobacillus infectionFAERS: 1US FAERS
939LaryngospasmFAERS: 1US FAERS
940LeukocytosisFAERS: 1US FAERS
941Lichen PlanusFAERS: 1US FAERS
942Ligament injuryFAERS: 1US FAERS
943Limb asymmetryFAERS: 1US FAERS
944Limb crushing injuryFAERS: 1US FAERS
945Lipids abnormalFAERS: 1US FAERS
946LipomaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
947Low birth weight babyFAERS: 1US FAERS
948Lung carcinoma cell type unspecified stage IFAERS: 1US FAERS
949Macular degenerationFAERS: 1US FAERS
950MalnutritionFAERS: 1US FAERS
951Mastication disorderFAERS: 1US FAERS
952Mechanical ventilationFAERS: 1US FAERS
953Medical device changeFAERS: 1US FAERS
954Medical device implantationFAERS: 1US FAERS
955Medical device painFAERS: 1US FAERS
956MeningiomaFAERS: 1US FAERS
957Mental FatigueFAERS: 1US FAERS
958Methylenetetrahydrofolate reductase gene mutationFAERS: 1US FAERS
959MiliariaFAERS: 1US FAERS
960Morganella infectionFAERS: 1US FAERS
961Motion SicknessFAERS: 1US FAERS
962Multi-organ disorderFAERS: 1US FAERS
963Multiple MyelomaFAERS: 1US FAERS
964Myasthenic SyndromeFAERS: 1US FAERS
965Mycobacterium tuberculosis complex test positiveFAERS: 1US FAERS
966MydriasisFAERS: 1US FAERS
967MyelitisFAERS: 1US FAERS
968MyoclonusFAERS: 1US FAERS
969Nail InfectionFAERS: 1US FAERS
970Nasal mucosal disorderFAERS: 1US FAERS
971Nasal pruritusFAERS: 1US FAERS
972Natural killer cell count decreasedFAERS: 1US FAERS
973Near DrowningFAERS: 1US FAERS
974Negative thoughtsFAERS: 1US FAERS
975NephritisFAERS: 1US FAERS
976NephrosclerosisFAERS: 1US FAERS
977Nephrotic SyndromeFAERS: 1US FAERS
978NeuroblastomaFAERS: 1US FAERS
979Neurogenic BowelFAERS: 1US FAERS
980Neuroleptic Malignant SyndromeFAERS: 1US FAERS
981Neurological procedural complicationFAERS: 1US FAERS
982Neutrophil percentage decreasedFAERS: 1US FAERS
983Nipple painFAERS: 1US FAERS
984Norovirus test positiveFAERS: 1US FAERS
985Obesity surgeryFAERS: 1US FAERS
986ObesityFAERS: 1US FAERS
987Obsessive-Compulsive DisorderFAERS: 1US FAERS
988Ocular RosaceaFAERS: 1US FAERS
989Ocular discomfortFAERS: 1US FAERS
990Ocular vascular disorderFAERS: 1US FAERS
991OnycholysisFAERS: 1US FAERS
992Optic AtrophyFAERS: 1US FAERS
993Optic NeuropathyFAERS: 1US FAERS
994Oral candidiasisFAERS: 1US FAERS
995Orthodontic appliance userFAERS: 1US FAERS
996OverweightFAERS: 1US FAERS
997Oxygen consumption decreasedFAERS: 1US FAERS
998PallorFAERS: 1US FAERS
999Pancreatic CystFAERS: 1US FAERS
1000Pancreatic NeoplasmFAERS: 1US FAERS
1001Pancreatic PseudocystFAERS: 1US FAERS
1002Paranasal sinus hypersecretionFAERS: 1US FAERS
1003ParaplegiaFAERS: 1US FAERS
1004Parasite stool test positiveFAERS: 1US FAERS
1005ParesisFAERS: 1US FAERS
1006Peptic UlcerFAERS: 1US FAERS
1007Peptostreptococcus infectionFAERS: 1US FAERS
1008Perforated ulcerFAERS: 1US FAERS
1009Pericardial effusionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1010PericarditisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1011Perioral DermatitisFAERS: 1US FAERS
1012Peripheral arterial occlusive diseaseFAERS: 1US FAERS
1013PeritonitisFAERS: 1US FAERS
1014PertussisFAERS: 1US FAERS
1015Phlebitis deepFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1016Physical deconditioningFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1017PityriasisFAERS: 1US FAERS
1018PneumonitisFAERS: 1US FAERS
1019PoisoningFAERS: 1US FAERS
1020Polymyalgia RheumaticaFAERS: 1US FAERS
1021Polyomavirus test positiveFAERS: 1US FAERS
1022Positron emission tomogram abnormalFAERS: 1US FAERS
1023Post lumbar puncture syndromeFAERS: 1US FAERS
1024Post procedural infectionFAERS: 1US FAERS
1025Post-traumatic neck syndromeFAERS: 1US FAERS
1026Potentiating drug interactionFAERS: 1US FAERS
1027Premenstrual syndromeFAERS: 1US FAERS
1028PriapismFAERS: 1US FAERS
1029Procalcitonin increasedFAERS: 1US FAERS
1030Procedural nauseaFAERS: 1US FAERS
1031Procedural vomitingFAERS: 1US FAERS
1032Product administration errorFAERS: 1US FAERS
1033Product compounding quality issueFAERS: 1US FAERS
1034Product container issueFAERS: 1US FAERS
1035Product container seal issueFAERS: 1US FAERS
1036Product contamination physicalFAERS: 1US FAERS
1037Product dispensing errorFAERS: 1US FAERS
1038Product dispensing issueFAERS: 1US FAERS
1039Product distribution issueFAERS: 1US FAERS
1040Product formulation issueFAERS: 1US FAERS
1041Product preparation errorFAERS: 1US FAERS
1042Product prescribing errorFAERS: 1US FAERS
1043Product quality control issueFAERS: 1US FAERS
1044Product residue presentFAERS: 1US FAERS
1045Product size issueFAERS: 1US FAERS
1046Product solubility abnormalFAERS: 1US FAERS
1047Product storage errorFAERS: 1US FAERS
1048Product substitutionFAERS: 1US FAERS
1049Product taste abnormalFAERS: 1US FAERS
1050Product used for unknown indicationFAERS: 1US FAERS
1051Protein total abnormalFAERS: 1US FAERS
1052Pseudomonal sepsisFAERS: 1US FAERS
1053Psychogenic seizureFAERS: 1US FAERS
1054Psychomotor skills impairedFAERS: 1US FAERS
1055Pubic painFAERS: 1US FAERS
1056Pulmonary HypertensionFAERS: 1US FAERS
1057PurulenceFAERS: 1US FAERS
1058Reaction to preservativesFAERS: 1US FAERS
1059Rebound effectFAERS: 1US FAERS
1060Red blood cell morphology abnormalFAERS: 1US FAERS
1061Red cell distribution width decreasedFAERS: 1US FAERS
1062Red man syndromeFAERS: 1US FAERS
1063Renal ColicFAERS: 1US FAERS
1064Renal cystFAERS: 1US FAERS
1065Respiratory DepressionFAERS: 1US FAERS
1066Respiratory tract congestionFAERS: 1US FAERS
1067Reticulocyte count abnormalFAERS: 1US FAERS
1068Retinal vascular thrombosisFAERS: 1US FAERS
1069RhabdomyolysisFAERS: 1US FAERS
1070Rheumatoid factor increasedFAERS: 1US FAERS
1071Saliva alteredFAERS: 1US FAERS
1072SclerodermaFAERS: 1US FAERS
1073Scoliosis surgeryFAERS: 1US FAERS
1074Serotonin SyndromeFAERS: 1US FAERS
1075Sex hormone binding globulin increasedFAERS: 1US FAERS
1076Sick relativeFAERS: 1US FAERS
1077Single functional kidneyFAERS: 1US FAERS
1078Sinus operationFAERS: 1US FAERS
1079Sjogren's SyndromeFAERS: 1US FAERS
1080Skeletal injuryFAERS: 1US FAERS
1081Skin WrinklingFAERS: 1US FAERS
1082Skin tightnessFAERS: 1US FAERS
1083Sleep disorder due to a general medical conditionFAERS: 1US FAERS
1084Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
1085Slow response to stimuliFAERS: 1US FAERS
1086Somatic symptom disorderFAERS: 1US FAERS
1087SomnambulismFAERS: 1US FAERS
1088Specific gravity urine decreasedFAERS: 1US FAERS
1089Speech rehabilitationFAERS: 1US FAERS
1090Spinal X-ray abnormalFAERS: 1US FAERS
1091Spinal artery thrombosisFAERS: 1US FAERS
1092Spinal cord herniationFAERS: 1US FAERS
1093Spinal meningioma benignFAERS: 1US FAERS
1094SplinterFAERS: 1US FAERS
1095Squamous cell carcinomaFAERS: 1US FAERS
1096Staphylococcal impetigoFAERS: 1US FAERS
1097Stool analysis abnormalFAERS: 1US FAERS
1098StrabismusFAERS: 1US FAERS
1099StuporFAERS: 1US FAERS
1100Sudden Cardiac DeathFAERS: 1US FAERS
1101Sudden onset of sleepFAERS: 1US FAERS
1102SunburnFAERS: 1US FAERS
1103Suture insertionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1104Symptom recurrenceFAERS: 1US FAERS
1105SyringomyeliaFAERS: 1US FAERS
1106TachyarrhythmiaFAERS: 1US FAERS
1107TachyphreniaFAERS: 1US FAERS
1108Testicular massFAERS: 1US FAERS
1109TetanyFAERS: 1US FAERS
1110Therapeutic product effect incompleteFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1111Therapeutic reaction time decreasedFAERS: 1US FAERS
1112Therapeutic response delayedFAERS: 1US FAERS
1113ThoracotomyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1114Throat cancerFAERS: 1US FAERS
1115Thrombotic strokeFAERS: 1US FAERS
1116Thyroglobulin increasedFAERS: 1US FAERS
1117Thyroid NeoplasmFAERS: 1US FAERS
1118Tobacco userFAERS: 1US FAERS
1119Toe operationFAERS: 1US FAERS
1120Tongue blisteringFAERS: 1US FAERS
1121Tongue pruritusFAERS: 1US FAERS
1122TrichorrhexisFAERS: 1US FAERS
1123Tympanic Membrane PerforationFAERS: 1US FAERS
1124UnderweightFAERS: 1US FAERS
1125Upper respiratory tract congestionFAERS: 1US FAERS
1126Upper respiratory tract infection bacterialFAERS: 1US FAERS
1127Upper-airway cough syndromeFAERS: 1US FAERS
1128Urethral ObstructionFAERS: 1US FAERS
1129Urinary incontinence surgeryFAERS: 1US FAERS
1130Urinary tract discomfortFAERS: 1US FAERS
1131Urinary tract inflammationFAERS: 1US FAERS
1132Urine chloride increasedFAERS: 1US FAERS
1133Urine flow decreasedFAERS: 1US FAERS
1134Uterine ProlapseFAERS: 1US FAERS
1135UveitisFAERS: 1US FAERS
1136VIIth nerve paralysisFAERS: 1US FAERS
1137Vaginal abscessFAERS: 1US FAERS
1138Vaginal erosionFAERS: 1US FAERS
1139VasculitisFAERS: 1US FAERS
1140Ventricular FibrillationFAERS: 1US FAERS
1141Vertebral body replacementFAERS: 1US FAERS
1142Vertebral column massFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1143Vestibular NeuronitisFAERS: 1US FAERS
1144Violence-related symptomFAERS: 1US FAERS
1145Vulvovaginal burning sensationFAERS: 1US FAERS
1146Vulvovaginal painFAERS: 1US FAERS
1147WheezingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1148Wound sepsisFAERS: 1US FAERS
1149Wrong drug administeredFAERS: 1US FAERS
1150hypertensive nephropathyFAERS: 1US FAERS
1151Angle Closure GlaucomaCanada Vigilance: 1Canada Vigilance
1152Catalepsy7675867CTD
1153Cervix carcinomaCanada Vigilance: 1Canada Vigilance
1154Dyspnea24378259CTD
1155HemiparaesthesiaCanada Vigilance: 1Canada Vigilance
1156Joint destructionCanada Vigilance: 1Canada Vigilance
1157Necrosis6850293CTD
1158Neurobehavioral Manifestations24378259CTD
1159Post-traumatic painCanada Vigilance: 1Canada Vigilance
1160Respiratory Insufficiency6784740CTD
1161Seizures

View details

CTD
1162Sialorrhea24378259CTD
1163Therapeutic product effect delayedCanada Vigilance: 1Canada Vigilance
1164Therapeutic product effect variableCanada Vigilance: 1Canada Vigilance
1165ThirstCanada Vigilance: 1Canada Vigilance
1166Thoracic vertebral fractureCanada Vigilance: 1Canada Vigilance
1167Wound infection bacterialCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.